The role of mTOR in memory CD8+ T‐cell differentiation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Immunological Reviews

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.0105-2896.2010.00898.xPMID 20536567PMCID PMC3760155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pillars Article: Cytotoxic T-cell Memory without Antigen. Nature. 1994. 369: 648-652.

  2013cited by this paper
• Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy

  2012cited by this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy

  2009cited by this paper
• Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses.

  2009cited by this paper
• S1P1 receptor overrides regulatory T cell-mediated immune suppression through Akt-mTOR

  2009cited by this paper
• Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

  2009influential reference
• Enhancing CD8 T-cell memory by modulating fatty acid metabolism

  2009influential reference
• Immunosuppressive Drugs in Kidney Transplantation

  2009influential reference
• mTOR regulates memory CD8 T cell differentiation

  2009cited by this paper
• The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

  2009influential reference
• Immunoregulatory functions of mTOR inhibition

  2009cited by this paper
• Developing an HIV cytotoxic T‐lymphocyte vaccine: issues of CD8 T‐cell quantity, quality and location

  2009cited by this paper
• A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.

  2009cited by this paper
• Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.

  2009cited by this paper
• Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates

  2008cited by this paper
• T-cell quality in memory and protection: implications for vaccine design

  2008cited by this paper
• Reduced exposure to calcineurin inhibitors in renal transplantation.

  2008cited by this paper
• Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.

  2008cited by this paper
• T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

  2008cited by this paper
• Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking

  2008cited by this paper
• Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.

  2008cited by this paper
• The TSC-mTOR signaling pathway regulates the innate inflammatory response.

  2008influential reference
• Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway

  2008cited by this paper
• The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

  2008cited by this paper
• Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

  2008cited by this paper
• Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.

  2008influential reference
• Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

  2008cited by this paper
• mTOR at the crossroads of T cell proliferation and tolerance.

  2007cited by this paper
• Reduced exposure to calcineurin inhibitors in renal transplantation.

  2007cited by this paper
• Defining the role of mTOR in cancer.

  2007cited by this paper
• Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7Rα mutant mice

  2007cited by this paper
• Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1

  2007cited by this paper
• Sirolimus exposure during the early post‐transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients

  2007cited by this paper
• Strength of Stimulus and Clonal Competition Impact the Rate of Memory CD8 T Cell Differentiation12

  2007cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• Expanding mTOR signaling

  2007cited by this paper
• Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

  2007cited by this paper
• The perfect mix: recent progress in adjuvant research

  2007cited by this paper
• Non‐redundant role for IL‐7R signaling for the survival of CD8+ memory T cells

  2007cited by this paper
• Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells

  2007cited by this paper
• Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.

  2007cited by this paper
• Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells

  2007cited by this paper
• Resolution of a chronic viral infection after interleukin-10 receptor blockade

  2006cited by this paper
• mTOR, translation initiation and cancer

  2006cited by this paper
• Dendritic cells: translating innate to adaptive immunity.

  2006cited by this paper
• Do CD8 effector cells need IL-7R expression to become resting memory cells?

  2006cited by this paper
• Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase

  2006cited by this paper
• Innate immune recognition of viral infection.

  2006cited by this paper
• Innate immune recognition of viral infection

  2006cited by this paper
• Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells1

  2006cited by this paper
• Translating innate immunity into immunological memory: implications for vaccine development.

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

  2006cited by this paper
• CD8+ T‐cell memory in tumor immunology and immunotherapy

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006influential reference
• T cell vaccines for microbial infections

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Regulation of Akt/PKB Ser473 phosphorylation.

  2005cited by this paper
• Plasmacytoid dendritic cells--virus experts of innate immunity.

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3

  2005cited by this paper
• Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

  2005cited by this paper
• Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

  2005cited by this paper
• Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1

  2005cited by this paper
• Rapamycin-resistant Proliferation of CD8+ T Cells Correlates with p27kip1 Down-regulation and bcl-xL Induction, and Is Prevented by an Inhibitor of Phosphoinositide 3-Kinase Activity*

  2004cited by this paper
• Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects

  2004cited by this paper
• Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets.

  2004influential reference
• Helping the CD8+ T-cell response

  2004cited by this paper
• Immunosuppressive drugs for kidney transplantation.

  2004cited by this paper
• Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo.

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells

  2003cited by this paper
• Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells

  2002cited by this paper
• Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells

  2002cited by this paper
• Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory

  2001cited by this paper
• Uncoupling p70s6 Kinase Activation and Proliferation: Rapamycin-Resistant Proliferation of Human CD8+ T Lymphocytes1

  2001cited by this paper
• Cutting Edge: Increased Expression of Bcl-2 in Antigen-Specific Memory CD8+ T Cells1

  2000cited by this paper
• Persistence of memory CD8 T cells in MHC class I-deficient mice.

  1999cited by this paper
• Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

  1998cited by this paper
• Immunological Memory and Protective Immunity: Understanding Their Relation

  1996cited by this paper
• RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.

  1994cited by this paper
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex

  1994cited by this paper
• RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.

  1994cited by this paper
• Cytotoxic T-cell memory without antigen

  1994cited by this paper
• Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast

  1991cited by this paper

• Can you have a cake and eat it? Comparing reducing mycophenolate versus switching to everolimus for kidney transplants with new-onset BKPyV-DNAemia.

  2025cites this paper
• mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients.

  2025cites this paper
• A review on mTOR inhibitor use and outcomes of COVID-19 among patients with kidney transplantation

  2025cites this paper
• Dendritic cell immunotherapy has its antitumor action improved by the LPS in the maturation process

  2025cites this paper
• mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors

  2025cites this paper
• Emerging roles for methionine metabolism in immune cell fate and function

  2025cites this paper
• Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy

  2025cites this paper
• ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies

  2025cites this paper
• Characterization of peripheral immune cells in kidney transplantation recipients under different immunosuppressive treatments

  2025cites this paper
• Graphene oxide-loaded rapamycin coating on airway stents inhibits stent-related granulation tissue hyperplasia.

  2024cites this paper
• Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies.

  2024cites this paper
• Rapamycin Prevents Expansion of Costimulation Blockade-resistant CD8+ Alloreactive Memory Cells following Depletional Induction in Renal Transplant Recipients.

  2024cites this paper
• Fatty acid oxidation in immune function

  2024cites this paper
• Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill children

  2024cites this paper
• Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion

  2024cites this paper
• Senescent T Cells in Age-Related Diseases

  2024cites this paper
• Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance

  2024cites this paper
• Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy

  2024cites this paper
• COVID and the Kidney: An Update.

  2024cites this paper
• Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

  2023cites this paper
• Effects of Sirolimus treatment on patients with β‐Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4 + and CD8 + T cells

  2023cites this paper
• Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant tuberculosis by inducing polyfunctional central memory T cell responses.

  2023cites this paper
• Short-range interactions between fibrocytes and CD8+ T cells in COPD bronchial inflammatory response

  2023cites this paper
• Translatomics to explore dynamic differences in immunocytes in the tumor microenvironment

  2023cites this paper
• The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies

  2023cites this paper
• mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients

  2023cites this paper
• Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors

  2023cites this paper
• Mesenchymal stromal cells affect CD8 naïve to memory subsets polarization by down-modulating IL12Rβ1 and IL2Rα signaling pathways

  2023cites this paper
• CTLA4-Ig Effectively Controls Clinical Deterioration and Immune Condition in a Murine Model of Foxp3 Deficiency

  2023cites this paper
• Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients

  2023cites this paper
• Vaccines for immune tolerance against autoimmune disease.

  2023cites this paper
• Exploration of the impact of multimode thermal therapy versus radiofrequency ablation on CD8+ T effector cells of liver malignancies based on single cell transcriptomics

  2023cites this paper
• Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps

  2023cites this paper
• Amniotic MSC affect CD8 naive polarization toward SLEC/MPEC subsets by down-modulating IL-12Rβ1 and IL-2Rα signaling pathways

  2023cites this paper
• IL-15 Blockade and Rapamycin Rescue Multifactorial Loss of Factor VIII from AAV-Transduced Hepatocytes in Hemophilia A Mice.

  2022cites this paper
• T cell senescence: A crucial player in autoimmune diseases.

  2022cites this paper
• Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

  2022cites this paper
• Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.

  2022cites this paper
• Metabolic alterations impair differentiation and effector functions of CD8+ T cells

  2022cites this paper
• Regulation of immune cell metabolism in health and disease: Special focus on T and B cell subsets

  2022cites this paper
• Leucine Supplementation in Cancer Cachexia: Mechanisms and a Review of the Pre-Clinical Literature

  2022cites this paper
• Targeting Immune Cell Metabolism for the Improvement of Cancer Therapy

  2022cites this paper
• Modulation of glucose metabolism by 2-Deoxy-D-Glucose (2DG) promotes IL-17 producing human T cell subsets

  2022cites this paper
• Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective.

  2022cites this paper
• Bi-steric mTORC1-selective Inhibitors activate 4EBP1 reversing MYC-induced tumorigenesis and synergize with immunotherapy

  2022cites this paper
• Persistent CAD activity in memory CD8+ T cells supports rRNA synthesis and ribosomal biogenesis required at rechallenge

  2021cites this paper
• mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapy

  2021cites this paper
• RvD1 treatment during primary infection modulates memory response increasing viral load during respiratory viral reinfection.

  2021cites this paper
• The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

  2021cites this paper
• Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?

  2021cites this paper
• Rapamycin Improves the Response of Effector and Memory CD8+ T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi

  2021cites this paper
• Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases

  2021cites this paper
• The Binary Model of Chronic Diseases Applied to COVID-19

  2021cites this paper
• mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication

  2021cites this paper
• The mechanism of hsa-miR-424-5 combining PD-1 through mTORC signaling pathway to stimulate immune effect and participate in Type 1 diabetes

  2020cites this paper
• Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8+ T Cell Memory and Delayed Tumor Progression

  2020cites this paper
• Resident memory T cells in tumor-distant tissues fortify against metastasis formation

  2020cites this paper
• mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?

  2020cites this paper
• Nutrition, Immunity and Viral Infections

  2020cites this paper
• CD4+ T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis

  2020cites this paper
• Metabolic interventions: A new insight into the cancer immunotherapy.

  2020cites this paper
• Searching for the real function of mTOR signaling in the regulation of PD-L1 expression

  2020cites this paper
• Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancer.

  2020cites this paper
• Transcriptome profiling of tolerogenic dendritic cells conditioned with dual mTOR kinase inhibitor, AZD8055.

  2020cites this paper
• IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype

  2019cites this paper
• Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

  2019cites this paper
• Mechanisms underlying T cell ageing

  2019cites this paper
• Quantitative analysis of T cell proteomes and environmental sensors during T cell differentiation

  2019cites this paper
• Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation

  2019cites this paper
• Tissue Cytokine IL-33 Modulates the Cytotoxic CD8 T Lymphocyte Activity During Nutrient Deprivation by Regulation of Lineage-Specific Differentiation Programs

  2019cites this paper
• Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

  2019cites this paper
• Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators

  2019cites this paper
• TCR signaling: it’s all about the numbers

  2019cites this paper
• mTOR signalling: jack-of-all-trades 1.

  2019cites this paper
• Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

  2019cites this paper
• mTOR Signaling pathway as a master regulator of memory CD8+ T‐cells, Th17, and NK cells development and their functional properties

  2019cites this paper
• Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients

  2019cites this paper
• The clock is ticking: the impact of ageing on T cell metabolism

  2019cites this paper
• The STING of inflammatory adjuvants: Is the Toll too high?

  2019influential citation
• STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice.

  2019cites this paper
• Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy

  2018cites this paper
• Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

  2018cites this paper
• Clonal expansion of vaccine-elicited T cells is independent of aerobic glycolysis

  2018cites this paper
• Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

  2018cites this paper
• Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression

  2018cites this paper
• Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus

  2018cites this paper
• Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy

  2018cites this paper
• Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia

  2018cites this paper
• Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.

  2018cites this paper
• Late Persistent Positive EBV Viral Load and Risk of Solid Cancer in Kidney Transplant Patients

  2017cites this paper
• The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells.

  2017cites this paper
• Tangeretin has anti-asthmatic effects via regulating PI3K and Notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice

  2017cites this paper
• Advancing Immunotherapy in Metastatic Breast Cancer

  2017cites this paper
• IL-21 Augments Rapamycin in Expansion of Alpha Fetoprotein Antigen Specific Stem-Cell-like Memory T Cells in vitro

  2017cites this paper
• Impact of age and cytomegalovirus on CD8+ T‐cell compartment remodeling after solid organ transplantation: A one‐year follow‐up study

  2017cites this paper
• The microbiome and transfusion in cancer patients.

  2017cites this paper
• Gut microbiota and hematopoietic stem cell transplantation: where do we stand?

  2017cites this paper
• Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment

  2017cites this paper
• The mTOR Pathway and Aging

  2016cites this paper
• The 4E-BP–eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes

  2016cites this paper